FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to pharmacology and medicine and concerns a combination containing a compound of formula 
(1) and one or more pharmaceutically active agents for treating cancer, a pharmaceutical composition containing said combination, a method of treating, and a market pack containing said combination.
EFFECT: invention provides high clinical effectiveness.
9 cl, 6 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION, INCLUDING A) PYRIMIDYLAMINOBENZAMIDE AND B) KINASE Thr315lle INHIBITOR | 2007 |
|
RU2481840C2 |
| COMBINATIONS OF THERAPEUTIC AGENTS FOR CANCER TREATMENT | 2007 |
|
RU2449788C2 |
| COMBINATIONS OF THERAPEUTIC AGENTS APPLICABLE FOR TREATING CANCER | 2007 |
|
RU2447891C2 |
| TYROSINE KINASE INHIBITORS | 2008 |
|
RU2445309C2 |
| TREATING TUBEROUS SCLEROSIS | 2007 |
|
RU2473343C2 |
| APPLICATION OF PYRIMIDYLAMINOBENZAMIDES FOR TREATMENT OF DISEASES SENSITIVE TO MODULATION OF KINASE Tie-2 ACTIVITY | 2006 |
|
RU2404776C2 |
| COMBINATION OF IAP AND FLT3 INHIBITORS | 2007 |
|
RU2456983C2 |
| COMBINATIONS OF HSP90 INHIBITOR | 2009 |
|
RU2519673C2 |
| COMBINATION OF PYRIMIDYLAMINOBENZAMIDE AND mTOR KINASE INHIBITOR | 2006 |
|
RU2443418C2 |
| NOVEL PYRIMIDINE AMIDE DERIVATIVES AND USE THEREOF | 2003 |
|
RU2378267C2 |
